pioglitazone and glimepiride
Active substance: PIOGLITAZONE HYDROCHLORIDE, GLIMEPIRIDE
TABLET · PIOGLITAZONE HYDROCHLORIDE 30 mg/1, GLIMEPIRIDE 2 mg/1
United StatesActive
Marketing holder: Prasco Laboratories
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- PIOGLITAZONE HYDROCHLORIDE · 30 mg/1
- GLIMEPIRIDE · 2 mg/1
Registration
- Registration number
- 66993-821
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 66993-821 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66993-821 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66993-821 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 66993-821 · Verified 2026-10-09 · open in source